Literature DB >> 30908300

Early Detection of Pancreatic Cancer in High-Risk Individuals: Where Do We Go From Here?

Phil A Hart1.   

Abstract

Pancreatic cancer is a lethal disease that is commonly diagnosed at a late stage. Screening asymptomatic patients is necessary for early detection, but this is not currently recommended in the general population. As demonstrated in the current study, an important number of patients at increased risk can be diagnosed using either MRI/magnetic resonance cholangiopancreatography or endoscopic ultrasound. Further collaborative efforts are needed to define the ideal population for testing and refine the current approach to pancreatic cancer surveillance.

Entities:  

Mesh:

Year:  2019        PMID: 30908300      PMCID: PMC6450722          DOI: 10.14309/ajg.0000000000000192

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.

Authors:  Salvatore Paiella; Gabriele Capurso; Giulia Martina Cavestro; Giovanni Butturini; Raffaele Pezzilli; Roberto Salvia; Marianna Signoretti; Stefano Crippa; Silvia Carrara; Isabella Frigerio; Claudio Bassi; Massimo Falconi; Elsa Iannicelli; Alessandro Giardino; Alessandro Mannucci; Andrea Laghi; Luigi Laghi; Luca Frulloni; Alessandro Zerbi
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

3.  Is Screening for Pancreatic Cancer in High-Risk Individuals One Step Closer or a Fool's Errand?

Authors:  Phil A Hart; Suresh T Chari
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-27       Impact factor: 11.382

4.  Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Authors:  Marcia Irene Canto; Jose Alejandro Almario; Richard D Schulick; Charles J Yeo; Alison Klein; Amanda Blackford; Eun Ji Shin; Abanti Sanyal; Gayane Yenokyan; Anne Marie Lennon; Ihab R Kamel; Elliot K Fishman; Christopher Wolfgang; Matthew Weiss; Ralph H Hruban; Michael Goggins
Journal:  Gastroenterology       Date:  2018-05-24       Impact factor: 22.682

5.  Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.

Authors:  Elena M Stoffel; Shannon E McKernin; Randall Brand; Marcia Canto; Michael Goggins; Cassadie Moravek; Arun Nagarajan; Gloria M Petersen; Diane M Simeone; Matthew Yurgelun; Alok A Khorana
Journal:  J Clin Oncol       Date:  2018-11-20       Impact factor: 44.544

6.  Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies.

Authors:  Juan E Corral; Karl F Mareth; Douglas L Riegert-Johnson; Ananya Das; Michael B Wallace
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-30       Impact factor: 11.382

7.  International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.

Authors:  Marcia Irene Canto; Femme Harinck; Ralph H Hruban; George Johan Offerhaus; Jan-Werner Poley; Ihab Kamel; Yung Nio; Richard S Schulick; Claudio Bassi; Irma Kluijt; Michael J Levy; Amitabh Chak; Paul Fockens; Michael Goggins; Marco Bruno
Journal:  Gut       Date:  2012-11-07       Impact factor: 23.059

  7 in total
  4 in total

Review 1.  A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.

Authors:  James T Yurkovich; Qiang Tian; Nathan D Price; Leroy Hood
Journal:  Nat Rev Clin Oncol       Date:  2019-10-16       Impact factor: 66.675

2.  Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.

Authors:  Touseef Ahmad Qureshi; Srinivas Gaddam; Ashley Max Wachsman; Lixia Wang; Linda Azab; Vahid Asadpour; Wansu Chen; Yibin Xie; Bechien Wu; Stephen Jacob Pandol; Debiao Li
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

Review 3.  Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.

Authors:  Touseef Ahmad Qureshi; Sehrish Javed; Tabasom Sarmadi; Stephen Jacob Pandol; Debiao Li
Journal:  Chin Clin Oncol       Date:  2022-02-09

4.  Prognosis and Clinical Characteristics of Patients with Pancreatic Ductal Adenocarcinoma Diagnosed by Endoscopic Ultrasonography but Indeterminate on Computed Tomography.

Authors:  Sung Woo Ko; Tae Hyeon Kim; Tae Jun Song; Seong-Hun Kim; Dong-Wan Seo; Jai Hoon Yoon; Chang Min Cho; Jae Hee Cho; Jun-Ho Choi; Dong Wook Lee; Sang Hyub Lee; Seung Bae Yoon; Tae Hoon Lee; Gwang Ha Kim; Hoon Jai Chun
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.